Noema Pharma Funding: $171M Raised, Series B (2023)
Noema Pharma is a Biotech company based in Basel, Switzerland. It has raised $171M in total funding. Latest round: Series B.
Noema Pharma funding overview
Noema Pharma is a Biotech company based in Basel, Switzerland. Noema Pharma has raised $171M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2023. The round record for Noema Pharma runs through 2023; nothing later has been disclosed. Investors on record include Sofinnova Partners, Polaris Partners, Forbion, Jeito Capital. 4 distinct backers are named across the disclosed rounds.
Noema Pharma at a glance
Total raised
$171M
Latest round
Series B
Latest round date
March 2023
Industry
Biotech
Headquarters
Basel, Switzerland
Notable investors
Sofinnova Partners, Polaris Partners, Forbion, Jeito Capital
Frequently asked about Noema Pharma funding
How much has Noema Pharma raised?
Noema Pharma has raised $171M in total disclosed funding across the rounds on record.
Who has invested in Noema Pharma?
Sofinnova Partners, Polaris Partners, Forbion, Jeito Capital are named among the investors backing Noema Pharma.
What was the latest Noema Pharma funding round?
The most recent disclosed round is a Series B, announced in March 2023.
Where is Noema Pharma based?
Noema Pharma is based in Basel, Switzerland.
What sector does Noema Pharma operate in?
Noema Pharma is tracked under Biotech from Basel, Switzerland, with $171M in disclosed funding.
When did Noema Pharma last raise?
The last disclosed Noema Pharma round closed in March 2023 at Series B.
Round data for Noema Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Basel and backer lists below.
